Luliconazole
CAS 187164-19-8
Overview
Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan
Anant Labs manufacture and furnish high quality Luliconazole impurities for global markets. Our Luliconazole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.







